The role of nitric oxide (NO) in the pathophysiology of gram-positive sepsis is uncertain. In inflammatory conditions, high-output NO production is catalyzed by the enzyme inducible nitric oxide synthase (iNOS). The ability of 2 strains of pneumococci, pneumococcal cell wall preparations, and purified pneumococcal capsule (Pnu-Imune 23) to trigger the production of iNOS protein and NO in RAW 264.7 murine macrophages was tested. Live pneumococci, oxacillin-killed pneumococci, and pneumococcal cell wall preparations stimulated the production of iNOS and NO by RAW 264.7 cells in the presence, but not the absence, of low concentrations of recombinant murine interferon-g. In contrast, purified pneumococcal capsule induced little or no iNOS or NO production by these cells. Thus, pneumococci stimulate high-output NO production by murine macrophages. The potential role of NO in the pathogenesis of pneumococcal sepsis deserves further study.
TNF is another potent immunomodulator produced by monocytes and macrophages during inflammatory conditions [8] . As with NO, TNF overproduction appears to lead to many of the physiologic derangements of sepsis [9] .
Gram-positive bacteria are an increasingly common cause of septic shock in humans. Between one-third and one-half of all cases of sepsis in the United States are caused by gram-positive organisms, and this proportion is expected to increase in the coming years [10] . While some reports suggest that TNF plays a role in gram-positive sepsis [11] [12] [13] , few studies have examined the role of NO and iNOS in these infections. Consequently, little is known about the ability of gram-positive organisms or their components to trigger NO or iNOS production. Lipoteichoic acid, a major constituent of gram-positive cell walls, has been implicated in the host inflammatory response. Lipoteichoic acid isolated from Staphylococcus aureus has been shown to stimulate the production of iNOS mRNA [14] , iNOS protein [15] , and NO [14] [15] [16] in J774 murine macrophages. We have previously reported that lipoteichoic acid isolated from viridans streptococci induced NO production and iNOS mRNA accumulation in RAW 264.7 murine macrophages in the presence of recombinant (r) IFN-g, while TNF secretion occurred in either the presence or absence of rIFN-g [17] . Sriskandan et al. [18] also found that live Streptococcus pyogenes in the presence of rIFN-g induced NO production in murine peritoneal macrophages.
Streptococcus pneumoniae is one of the most important grampositive organisms that causes invasive human disease, including pneumonia, peritonitis, meningitis, and sepsis. The few recent studies that have evaluated NO or iNOS production in response to pneumococci have used rat central nervous system cells (astrocytes and microglia) [19] [20] [21] . No information is available regarding the ability of pneumococci or its components to trigger NO or iNOS production by macrophages, the cells that play a critical role in the host response to sepsis. Pneumococci have been reported to trigger TNF production in murine macrophages [22] and human monocytes [23, 24] . In addition, elevated TNF concentrations in lung tissue, serum, and cerebrospinal fluid have been found in invasive pneumococcal disease in both experimental animals and patients [25, 26] .
In this study, we assessed the ability of 2 strains of pneumococci, their purified cell walls, and capsular polysaccharide to induce NO, iNOS, and TNF production in the murine macrophage cell line RAW 264.7.
Materials and Methods
Reagents. Dulbecco's MEM (DMEM) was purchased from Mediatech (Herndon, VA). L-glutamine, penicillin, and streptomycin were purchased from Gibco (Grand Island, NY). Fetal bovine serum containing !0.06 EU/mL by limulus amebocyte assay was purchased from HyClone Laboratories (Logan, UT). Pneumococcal strain 6303 was purchased from American Type Culture Collection (ATCC; Rockville, MD). Pneumococcal strain 124, a clinical isolate from a child with sepsis, was provided by J. Shenep (St. Jude Children's Research Hospital, Memphis). LPS purified from Escherichia coli O111:B4 was purchased from Sigma (St. Louis). Mouse rIFN-g was purchased from Genzyme (Cambridge, MA). Polymyxin B (PMB) was purchased from Pfizer (New York). Oxacillin was purchased from Marsham Pharmaceuticals (Cherry Hill, NJ). The pneumococcal vaccine Pnu-Imune 23 was purchased from Lederle Laboratories (Pearl River, NY).
Pneumococcal cell wall preparations. Pneumococcal cell wall preparations (PCWP) were prepared as previously described [27, 28] . Briefly, pneumococci from glycerol culture were resuspended in CϩY medium [27] and grown to an optical density at 620 nm of 0.5 ( cfu/mL). The culture was then chilled in iced 8 1.5 ϫ 10 ethanol to prevent autolysis and centrifuged at 4ЊC at 4000 g. After discarding the supernatant, the pellets were resuspended in cold 50 mM Tris-HCl and placed in boiling 5% SDS for 15 min to inactivate the autolysin. The suspension was cooled to room temperature and then centrifuged for 10 min at 12,000 g. The pellet was resuspended in 1 M NaCl. Multiple sequential washes with 1 M NaCl followed by distilled H 2 O were done on the new suspension, followed by centrifugation for 10 min at 12,000 g. The pellet was resuspended in H 2 O, added to an equal volume of acid-washed glass beads, and vortexed to break the cells. Glass beads were removed by sintered glass filter. The filtrate was centrifuged for 5 min at 27,000 g, and supernatant was discarded. The remaining pellet, the cell wall, was resuspended in 100 mM Tris and 20 mM MgSO 4 . DNase, 10 mg/ mL, and RNase, 50 mg/mL, were added to degrade DNA and RNA. Protein degradation was done by addition of trypsin, 100 mg/mL, and 10 mM CaCl 2 . The sample was vacuum-dried and stored at room temperature until ready for use, when it was resuspended in DMSO.
Approximately ng of cell wall is equivalent to 10 7 pneu-3 2 ϫ 10 mococci [27, 28] .
Cells and cell culture. RAW 264.7 cells were purchased from ATCC and cultured in DMEM supplemented with 10% fetal bovine serum and 2 mM L-glutamine. In experiments designed to measure nitrite accumulation, DMEM without pH indicator dye was used. Penicillin G, 50 U/mL, and streptomycin, 50 mg/mL, were added to DMEM except in experiments with whole organisms. Experiments done in 6-well tissue culture plates (Becton Dickinson, Lincoln Park, NJ) contained 4.06-cells/well. Those done in 6 5.04 ϫ 10 24-well tissue culture plates (Sarstedt, Newton, NC) contained 0.74-cells/well. Experiments used negative controls of 6 0.85 ϫ 10 media alone and positive controls of LPS plus rIFN-g. When PMB was used, it was added 1 h before stimulation. Oxacillin was added to the cells at the same time as live pneumococcal strains. The concentration of oxacillin approximated human serum levels at normal dosing. Cells were stimulated with the appropriate reagents for 18 h, unless otherwise stated. In kinetics experiments, the cells were stimulated for intervals of 2, 4, 6, and 18 h with rIFN-g and PCWP or LPS.
Immunoblotting. For Western blotting, cells were lysed in extraction buffer (20 mM Tris, 100 mM NaCl, 1% Triton X-100, 50 mM NaF, 1 mM Na 3 VO 4 , 0.2 mM phenylmethylsulfonyl fluoride, 10 mg/mL leupeptin, and 10 mg/mL aprotinin). Lysates, 100 mg of protein each, were electrophoresed on 7.5% SDS-polyacrylamide gels, transferred to nitrocellulose membranes, and blocked overnight in 5% milk. Nitrocellulose membranes were reacted with mouse monoclonal antibody to macrophage iNOS (Transduction Laboratories, Lexington, KY). Blots were then reacted with a sheep anti-mouse IgG peroxidase-linked conjugate (Amersham, Arlington Heights, IL). Proteins were detected by enhanced chemiluminescence (Amersham).
Nitrite assay. The presence of nitrite in cell culture supernatants was determined by the Griess reaction [29] . Aliquots of 200 mL or RAW 264.7 cells were added to 96-well tissue culture plates 5 1 ϫ 10 (Costar, Cambridge, MA), which were incubated for 4-6 h. Stimuli were then added; microplates were kept at 37ЊC in 5% CO 2 for 18-24 h. At harvest by centrifugation, 100 mL of supernatant or nitrite standard was added to a new 96-well plate. One hundred microliters of Griess reagent (equal quantities of 1% sulfanilamide in 5% H 3 PO 4 and 0.1% naphthylethylene in H 2 0) was added to each well, and plates were read at 550 nm. Determination of TNF concentrations. Cell-free supernatants were plated on a solid-phase sandwich ELISA specific for murine TNF, as specified by the manufacturer (Genzyme).
Results
PCWP stimulated iNOS production in the presence of rIFNg. PCWP purified from both pneumococcal strains tested (ATCC 6303 and clinical isolate 124) were found to induce iNOS protein accumulation in RAW 264.7 macrophages in a dose-dependent fashion in the presence of rIFN-g (figures 1A and 1B are representative experiments;
). Cells exposed to n ϭ 4 PCWP failed to produce iNOS protein in the absence of rIFNg. When each was used alone, rIFN-g and LPS induced small amounts of detectable iNOS protein. LPS plus rIFN-g was used as a positive control and consistently induced greater iNOS protein accumulation than did the highest tested concentration of PCWP (10 4 ng/mL) plus rIFN-g. Whole pneumococci stimulated iNOS production in the pres- ence of rIFN-g. Live pneumococcal organisms were added to RAW 264.7 cells at initial concentrations of 10 4 -10 7 cfu/mL. In the presence, but not absence, of rIFN-g, all concentrations of the 6303 isolate induced large amounts of iNOS protein (data not shown). Likewise, iNOS protein was induced by 10 4 cfu/ mL live pneumococcal strain 124 only in the presence of rIFNg. The three highest concentrations of the 124 strain killed the RAW cells by the harvest time of 18 h (data not shown).
Because of the toxicity of live bacteria, we subsequently studied the ability of antibiotic-killed pneumococci to induce iNOS production. Oxacillin at 40 mg/mL was added to RAW cells concurrently with live pneumococcal strains. Antibiotic-killed pneumococci failed to induce iNOS protein in the absence of rIFN-g (figures 2A and 2B are representative experiments;
). However, in the presence of rIFN-g, iNOS protein was n ϭ 3 produced in a dose-dependent fashion in response to concentrations of 10 4 -10 6 cfu/mL of both pneumococcal strains ( ). Neither strain of antibiotic-killed pneumococci (with n ϭ 5 rIFN-g) stimulated iNOS production at concentrations of 10 3 cfu/mL. Oxacillin alone had no effect on iNOS production.
PCWP and antibiotic-killed pneumococci induced NO production in the presence of rIFN-g. As with iNOS protein production, PCWP (figures 1C and 1D are representative experiments;
) and oxacillin-killed pneumococci (figures 2C and n ϭ 5 2D are representative experiments;
) required the presence n ϭ 5 of rIFN-g to stimulate production of NO in RAW 264.7 cells. NO accumulated in a dose-dependent fashion, in response to the same concentrations of PCWP used in the iNOS experiments (10 1 -10 4 ng/mL). No significant difference was noted between the 6303 and 124 strains.
Production of iNOS and NO in response to PCWP was not due to endotoxin contamination. RAW 264.7 cells were preincubated with PMB, a potent endotoxin inhibitor. PCWP of both strains 6303 and 124 in concentrations ranging from 10 1 to 10 4 ng/mL were added to cells simultaneously with rIFN-g.
In five of six experiments, there was no decrement in the amount of iNOS protein induced after stimulation of RAW cells with PCWP plus rIFN-g in the presence of PMB (figures 3A and 3B are representative experiments).
As we have previously reported [30] , iNOS protein production by RAW 264.7 cells stimulated with LPS plus rIFN-g was consistently inhibited by PMB (data not shown). Likewise, NO accumulation by RAW 264.7 macrophages in response to PCWP plus rIFN-g was unaffected by preincubation with PMB ( figures 3C and 3D are representative experiments; ). n ϭ 5 PCWP induced iNOS production in a time-dependent manner. RAW 264.7 cells were stimulated at time 0 with media, rIFNg alone, PCWP plus rIFN-g, or LPS plus rIFN-g, and lysates were harvested at 2, 4, 6, and 18 h ( figure 4 is a representative  experiment; ). In these experiments, no iNOS production n ϭ 2 was noted in response to the tested concentrations of PCWP until 18 h. In comparison, cells stimulated with LPS plus rIFNg showed a strong positive response at both 6 and 18 h.
Antibiotic-killed pneumococci and PCWP stimulated TNF production in a dose-dependent fashion. Antibiotic-killed pneumococci elicited production of TNF at concentrations of ≥10 4 cfu/mL with or without rIFN-g. Similar amounts of TNF were induced by the higher concentrations of antibiotic-killed pneumococci (10 6 -10 7 cfu/mL) and by LPS when each was administered in the presence of rIFN-g. Oxacillin alone failed to induce TNF production. In contrast, PCWP induced little or no TNF in the absence of rIFN-g. When rIFN-g was added to PCWP, the highest concentrations of both strains led to macrophage TNF release greater than that seen with media or rIFN-g alone ( figure 5 is representative; ). n ϭ 4 Pneumococcal capsular polysaccharide induced little or no iNOS, NO, or TNF production by RAW 264.7 cells. Stimulation of RAW 264.7 macrophages with concentrations of pneumococcal capsule ranging from 10 0 to 10 4 ng/mL, with or without rIFN-g for 18 h, had little or no effect on the production of iNOS, NO, or TNF by these cells. In the absence of rIFN-g, capsule failed to induce iNOS, NO, or TNF production by these cells. In the presence of low doses of rIFN-g, small amounts of iNOS protein (but no NO or TNF) were induced by exposure of RAW cells to the highest concentration of capsule tested (10 4 ng/mL; not shown).
Discussion
We have shown that whole pneumococci and purified pneumococcal cell wall preparations triggered the production of iNOS, NO, and TNF by murine macrophages. Under all conditions, induction of iNOS and NO production required the presence of low concentrations of rIFN-g. In contrast, antibiotic-killed pneumococci stimulated TNF secretion in the absence of rIFN-g, while purified cell walls necessitated its addition. These findings differ from studies of the response of glial cells and astrocytes to pneumococci. For example, Bernatowicz et al. [19] stimulated astrocyte cultures with 10 6 -10 8 cfu/mL heat-killed unencapsulated pneumococci alone and found significantly increased NO accumulation after 24-72 h of incubation. Likewise, Kim et al. [20] found that purified pneumococcal cell walls (without rIFN-g) stimulated astrocytes and microglia to produce NO. However, these investigators used cell wall concentrations of ng/mL, much greater 5 2 ϫ 10 than our experimental maximum of 10 4 ng/mL. Because 1 ng/ mL of cell wall preparation corresponds to roughly cfu/ 3 5 ϫ 10 mL of pneumococci [27, 28] , we studied a range of PCWP concentrations (10 1 -10 4 ng/mL) corresponding to to 4 ∼ 5 ϫ 10 organisms/mL. It is possible that we would have de- 7 5 ϫ 10 tected some NO or iNOS production in macrophages stimulated with pneumococci in the absence of rIFN-g had we extended the exposure time or increased the concentration of organisms, but the significance of these observations would have been uncertain.
Our finding that costimulation with IFN-g was required for induction of iNOS and NO production by macrophages parallels the results of studies of other gram-positive bacteria [18, [31] [32] [33] and their components (e.g., lipoteichoic acid from viridans streptococci, pyrogenic exotoxins from group A streptococci) [17, 34] . IFN-g directly up-regulates iNOS production [35, 36] and augments macrophage production of iNOS/NO and other inflammatory mediators in response to LPS and other bacterial products [36] . Some bacteremic patients have elevated serum concentrations of IFN-g [37] , and animal models suggest that this cytokine may play an important role in sepsis [38, 39] .
We also evaluated the ability of pneumococci and its components to stimulate TNF production in murine macrophages.
Previous work in animal models has suggested that cell wall components of pneumococci promote inflammation, while capsule has little activity [27, 28] . We found that PCWP required the presence of rIFN-g to induce macrophage TNF production above that of media or rIFN-g alone, correlating with our findings regarding the high-output NO pathway. In contrast, antibiotic-killed whole organism stimulated TNF production in a dose-dependent fashion, without the concomitant addition of rIFN-g. This result suggests that pneumococcal components other than those in the cell wall also contribute to macrophage activation by these organisms. However, we saw little or no effect of purified pneumococcal capsule (Pnu-Imune 23) on TNF, NO, or iNOS production by RAW 264.7 cells. Simpson et al. [22] reported that stimulation of RAW 264.7 cells by similar concentrations (10 pg/mL to 10 mg/mL) of 23-valent pneumococcal vaccine from the same manufacturer triggered large amounts of TNF production. We were unable to reproduce these findings, even in the presence of rIFN-g. It might be instructive to test the response of RAW 264.7 cells to capsule purified from the two pneumococcal strains that we have studied.
In summary, we have shown that pneumococci induce NO, iNOS, and TNF production in murine macrophages. IFN-g is a necessary adjunct to whole organisms or cell wall in the stimulation of NO and iNOS production by these cells. Additional study of the potential role of NO and iNOS in the pathogenesis of pneumococcal infection is warranted.
